Chase Knickerbocker
Analyst, Craig-Hallum Capital Group
Replay available
Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) Q4 2025 earnings conference call, held 2026-03-19. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Madison Asadi
Analyst, B. Riley Securities
Ipek Trinkas
Chief Commercial Officer
James Gruber
Chief Financial Officer
Sean Brinjelson
Chief Executive Officer
David Krempa
Chief Business Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Eton Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.977 Good afternoon and welcome to the Eaton Pharmaceuticals fourth quarter 2025 financial 00:00:06.979 -- 00:00:12.847 results conference call. At this time, all participants are in a listen-only mode. 00:00:12.847 -- 00:00:17.752 Following the formal remarks, we will open the call up for your questions. 00:00:17.752 -- 00:00:23.059 Please be advised that this call is being recorded at the company's request. 00:00:23.059 -- 00:00:26.845 At this time, I'd like to turn it over to David Krempa. 00:00:26.845 -- 00:00:29.808 Chief Business Officer at Eaton Pharmaceuticals. 00:00:29.808 -- 00:00:32.169 Please proceed. 00:00:33.192 -- 00:00:37.817 Thank you, Operator. Good afternoon, everyone, and welcome to Eaton's fourth quarter 00:00:37.817 -- 00:00:42.902 2025 conference call. This afternoon, we issued a press release that outlines 00:00:42.902 -- 00:00:46.446 the topics we plan to discuss on today's call. 00:00:46.446 -- 00:00:50.328 The release is available on our website, eatonpharma.com. 00:00:50.550 -- 00:00:55.916 Joining me on our call today, we have Sean Brinjelson, our CEO, James Gruber, 00:00:55.916 -- 00:01:00.963 our CFO, and Ipek Trinkas, our Chief Commercial Officer. 00:01:00.963 -- 00:01:05.931 In addition to taking live questions on today's call, we will also be answering questions 00:01:05.931 -- 00:01:12.639 that are emailed to us. Investors can send their questions to investorrelations at eatonfarman.com. 00:01:12.763 -- 00:01:17.931 Before we begin, I would like to remind everyone that remarks made during this call may 00:01:17.931 -- 00:01:23.187 contain forward-looking statements and involve risks and uncertainties that could cause 00:01:23.187 -- 00:01:28.853 actual results to differ materially from those contained ...